rosuvastatin accord 5 mg filmtabletten
accord healthcare b.v. - rosuvastatin calcium -
trigelan 100 mg/25 mg/200 mg-filmtabletten
g.l. pharma gmbh - carbidopa monohydrat; entacapon; levodopa -
trigelan 125 mg/31,25 mg/200 mg-filmtabletten
g.l. pharma gmbh - carbidopa monohydrat; entacapon; levodopa -
trigelan 150 mg/37,5 mg/200 mg-filmtabletten
g.l. pharma gmbh - carbidopa monohydrat; entacapon; levodopa -
trigelan 175 mg/43,75 mg/200 mg-filmtabletten
g.l. pharma gmbh - carbidopa monohydrat; entacapon; levodopa -
trigelan 200 mg/50 mg/200 mg-filmtabletten
g.l. pharma gmbh - carbidopa monohydrat; entacapon; levodopa -
trigelan 50 mg/12,5 mg/200 mg-filmtabletten
g.l. pharma gmbh - carbidopa monohydrat; entacapon; levodopa -
trigelan 75 mg/18,75 mg/200 mg-filmtabletten
g.l. pharma gmbh - carbidopa monohydrat; entacapon; levodopa -
ciambra
menarini international operations luxembourg s.a. - pemetrexeddinatriumhemipentahydrat - carcinoma, non-small-cell lung; mesothelioma - antineoplastische mittel - malignant pleural mesothelioma ciambra in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancer ciambra in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. ciambra ist indiziert als monotherapie für die wartung behandlung von lokal fortgeschrittenem oder metastasierendem nicht-kleinzelligem lungenkrebs anderen als überwiegend plattenepithel-histologie bei patienten, deren krankheit nicht fortgeschritten ist sofort nach der platin-basierten chemotherapie. ciambra ist indiziert als monotherapie für die zweitlinientherapie von patienten mit lokal fortgeschrittenem oder metastasiertem nicht-kleinzelligem lungenkrebs andere als plattenepithelkarzinom klassifiziert ist.
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastische mittel - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.